Skip to content

Predicting the likelihood of weight gain as a side effect of psychiatric medications and the effectiveness of anti-obesity drugs: A pilot study

Predicting the likelihood of weight gain as a side effect of psychiatric medications and the effectiveness of anti-obesity drugs: A pilot study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009769
Enrollment
300
Registered
2024-09-06
Start date
2024-09-09
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chung-Ang Univerisity Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Adults aged 19 years or older B. Individuals diagnosed with depression, bipolar disorder, or schizophrenia according to the DSM-5 diagnostic criteria C. Individuals with no history of using olanzapine, quetiapine, aripiprazole, mirtazapine, or valproate within 1 month prior to the initial assessment D. Individuals with no history of using anti-obesity medications for weight loss purposes within 1 month prior to the initial assessment

Exclusion criteria

Exclusion criteria: A. Individuals with severe medical conditions (e.g., cancer, heart failure, kidney failure, liver disease, lung disease, thyroid disorders, or acute inflammatory conditions) B. Individuals with a history of substance dependence or abuse, either past or present C. Individuals with a history of epilepsy, head trauma, or organic mental disorders

Design outcomes

Primary

MeasureTime frame
Body composition factors (e.g., weight, body mass index, body fat mass, muscle mass, etc.)

Secondary

MeasureTime frame
Dietary assessment;The Korean Version of Eating Attitudes Test-26;International Physical Activity Questionnaire;(Alcohol Use Disorder Identification Test;Insomnia Severity Index-Korean;Hematological factors (e.g., insulin, fasting blood glucose, lipids, uric acid, high-sensitivity CRP etc.);Positive and Negative Syndrome Scale;Beck Depression Inventory–II;Mood Disorder Questionnaire

Countries

Korea, Republic of

Contacts

Public ContactNa Yeon Kim

Chung-Ang Univerisity Hospital

npny8953@caumc.or.kr+82-2-6299-1508

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026